(D02) Carcinoma in situ of middle ear and respiratory system

More details coming soon

Icon
45 605 in individuals diagnosis carcinoma in situ of middle ear and respiratory system confirmed
Icon
6 065 deaths with diagnosis carcinoma in situ of middle ear and respiratory system
Icon
13% mortality rate associated with the disease carcinoma in situ of middle ear and respiratory system

Diagnosis carcinoma in situ of middle ear and respiratory system is diagnosed Men are 42.27% more likely than Women

32 442

Men receive the diagnosis carcinoma in situ of middle ear and respiratory system

792 (2.4 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
13 163

Women receive the diagnosis carcinoma in situ of middle ear and respiratory system

5 273 (40.1 %)

Died from this diagnosis.

Risk Group for the Disease carcinoma in situ of middle ear and respiratory system - Men aged 60-64 and Women aged 55-59

Icon
In Men diagnosis is most often set at age 0-9, 15-29, 40-94
Icon
Less common in men the disease occurs at Age 0-1, 10-14, 30-39, 95+Less common in women the disease occurs at Age 0-1, 5-9, 30-39, 90-95+
Icon
In Women diagnosis is most often set at age 0-5, 10-29, 40-89

Disease Features carcinoma in situ of middle ear and respiratory system

Icon
Absence or low individual and public risk
Icon

Carcinoma in situ of middle ear and respiratory system - what does this mean

Carcinoma in situ of middle ear and respiratory system is a type of cancer where abnormal cells have been found in the middle ear or respiratory system, but they have not spread to nearby tissue. it is usually caused by exposure to carcinogens such as tobacco smoke, asbestos, or radiation. it can also be caused by genetic factors. early diagnosis and treatment is important for successful treatment.

What happens during the disease - carcinoma in situ of middle ear and respiratory system

Carcinoma in situ of the middle ear and respiratory system is caused by the abnormal growth of cells in the mucous membranes of the middle ear and respiratory tract. this abnormal growth is caused by the mutation of certain genes in the cells, which leads to uncontrolled growth and the formation of tumors. the tumors can then spread to the other parts of the respiratory and middle ear systems, leading to further complications.

Clinical Pattern

Carcinoma in situ of the middle ear and respiratory system is a condition where abnormal cells are present in the middle ear and respiratory system, but they have not spread beyond the layer of tissue in which they began. Symptoms may include hearing loss, ear pain, dizziness, and ringing in the ears. In addition, patients may experience difficulty breathing, coughing, and chest pain. Diagnosis is made through imaging studies such as CT scans and MRI, as well as biopsies of the affected tissue. Treatment typically involves surgical removal of the abnormal cells, as well as radiation therapy and chemotherapy to reduce the risk of recurrence.

How does a doctor diagnose

More details coming soon

Treatment and Medical Assistance

More details coming soon
Icon
15 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Carcinoma in situ of middle ear and respiratory system - Prevention

The best way to prevent carcinoma in situ of the middle ear and respiratory system is to avoid exposure to carcinogenic substances, such as cigarette smoke, and to practice good hygiene, such as washing hands regularly and avoiding contact with those who are ill. additionally, regular check-ups with a primary care provider can help to identify any early signs of cancer and allow for early treatment.

Specified forms of the disease

(D02.0) Carcinoma in situ: Larynx
(D02.1) Carcinoma in situ: Trachea
(D02.2) Carcinoma in situ: Bronchus and lung
(D02.3) Carcinoma in situ: Other parts of respiratory system
(D02.4) Carcinoma in situ: Respiratory system, unspecified